788 related articles for article (PubMed ID: 30443279)
1. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(7):1-199. PubMed ID: 30443279
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
[TBL] [Abstract][Full Text] [Related]
3. Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure.
Elsner C; Bettin S; Tilz R; Häckl D
Curr Heart Fail Rep; 2024 Jun; 21(3):186-193. PubMed ID: 38662154
[TBL] [Abstract][Full Text] [Related]
4. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
6. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
[TBL] [Abstract][Full Text] [Related]
7. Remote monitoring of cardiac implantable devices in the Asia-Pacific.
Lau CP; Zhang S
Europace; 2013 Jun; 15 Suppl 1():i65-i68. PubMed ID: 23737235
[TBL] [Abstract][Full Text] [Related]
8. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
9. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring.
Heidbuchel H; Hindricks G; Broadhurst P; Van Erven L; Fernandez-Lozano I; Rivero-Ayerza M; Malinowski K; Marek A; Romero Garrido RF; Löscher S; Beeton I; Garcia E; Cross S; Vijgen J; Koivisto UM; Peinado R; Smala A; Annemans L
Eur Heart J; 2015 Jan; 36(3):158-69. PubMed ID: 25179766
[TBL] [Abstract][Full Text] [Related]
10. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up.
Buchta P; Tajstra M; Kurek A; Skrzypek M; Świetlińska M; Gadula-Gacek E; Wasiak M; Pyka Ł; Gąsior M
Kardiol Pol; 2017; 75(6):573-580. PubMed ID: 28150288
[TBL] [Abstract][Full Text] [Related]
11. Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study.
Sapp JA; Gillis AM; AbdelWahab A; Nault I; Nery PB; Healey JS; Raj SR; Lockwood E; Sterns LD; Sears SF; Wells GA; Yee R; Philippon F; Tang A; Parkash R
CMAJ Open; 2021; 9(1):E53-E61. PubMed ID: 33495385
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.
Hummel JP; Leipold RJ; Amorosi SL; Bao H; Deger KA; Jones PW; Kansal AR; Ott LS; Stern S; Stein K; Curtis JP; Akar JG
J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1066-1077. PubMed ID: 30938894
[TBL] [Abstract][Full Text] [Related]
13. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
[TBL] [Abstract][Full Text] [Related]
15. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
16. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(12):1-134. PubMed ID: 33240453
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF.
Ricci RP; D'Onofrio A; Padeletti L; Sagone A; Vicentini A; Vincenti A; Morichelli L; Cavallaro C; Ricciardi G; Lombardi L; Fusco A; Rovaris G; Silvestri P; Guidotto T; Pollastrelli A; Santini M
Europace; 2012 Nov; 14(11):1661-5. PubMed ID: 22544910
[TBL] [Abstract][Full Text] [Related]
19. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
